Table 2.

Reduced long-term hematopoietic reconstitution potential of expanded cells that are cycling at transplantation

G0/G1S/G2/MP Value
1° Recipients, n:  15  6  
 Total leukocytes  77 ± 5  39 ± 14  .04  
 B cells 87 ± 5  48 ± 15  .05  
 T cells  62 ± 4 29 ± 11  .03  
 Myeloid cells  65 ± 7 22 ± 11  .007  
2° Recipients, n:   9  
 Total leukocytes  52 ± 8  15 ± 12  .04  
 B cells  66 ± 8  21 ± 16  .05  
 T cells 39 ± 5  14 ± 10  .06  
 Myeloid cells 40 ± 12  22 ± 17  .04 
G0/G1S/G2/MP Value
1° Recipients, n:  15  6  
 Total leukocytes  77 ± 5  39 ± 14  .04  
 B cells 87 ± 5  48 ± 15  .05  
 T cells  62 ± 4 29 ± 11  .03  
 Myeloid cells  65 ± 7 22 ± 11  .007  
2° Recipients, n:   9  
 Total leukocytes  52 ± 8  15 ± 12  .04  
 B cells  66 ± 8  21 ± 16  .05  
 T cells 39 ± 5  14 ± 10  .06  
 Myeloid cells 40 ± 12  22 ± 17  .04 

The expanded progeny of Sca-1+c-kit+Lin BM cells (Ly-5.2+) were labeled with HO dye, sorted into G0/G1 or S/G2/M fractions, and injected into lethally irradiated Ly-5.1 mice (106cells/mouse). The data shown are the mean ± SEM percentage of Ly-5.2+ blood cells measured 4 months later (pooled data from 3 experiments). Primary BM cells were then transplanted into secondary mice (0.5 femur/mouse), which were analyzed after 10 weeks.P values represent comparisons of engraftment by G0/G1 and S/G2/M cells.

Close Modal

or Create an Account

Close Modal
Close Modal